Evaluating the risk of cancer in patients with oral lichen planus

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the rate of malignant transformation in patients diagnosed with oral lichen planus (OLP) over a long-term follow-up period. It will also explore the clinical characteristics of these patients to identify potential risk factors associated with malignant transformation. The study will analyze data from a cohort of patients to evaluate therapeutic effects and features related to OLP. By understanding these factors, the research seeks to provide insights into the management of OLP and its potential progression to oral carcinoma.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical-histological diagnosis of Oral lichen planus
* Patients who gave consensus to personal data treatment
* Minimum 6 months follow-up

Exclusion Criteria:

* Patients who did not give consensus to personal data treatment
* Oral lichenoid lesions
* Patients with anamnesis of hematopoietic stem cells transplant
* Patients with a OSCC at the first histological examination (i.e., namely: also OSCC patients with a OLP background were excluded)

Where it's running

• Catholic University of the Sacred Heart
  Roma, Italy Recruiting

Study contacts

• Study coordinator: Carlo Lajolo Associate Professor, DDS, MD, PhD
• Email: carlo.lajolo@unicatt.it
• Phone: 3356078354

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers

  This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.

  Recruiting British University In Egypt · Cairo · NCT07915570

• OROSEDAL use in sore throat and minor oral lesions

  This is a real-world, non-interventional study checking how well OROSEDAL works and how safe it is in people aged 8 and older who have sore throats or small mouth lesions in routine clinical practice.

  Recruiting Laboratoires Elerte · Multiple Locations · NCT07620353

• Light-based therapies versus clobetasol gel for erosive oral lichen planus

  This trial will test whether two light-based treatments (photobiomodulation or photodynamic therapy) or standard topical clobetasol better heal erosive oral lichen planus, reduce pain, and prevent recurrence in adults.

  Recruiting Medical University of Silesia · Zabrze, Silesian Voivodeship · NCT07278999

• Adding oral tofacitinib to topical steroid ointment for moderate-to-severe oral lichen planus

  This study will test whether taking oral tofacitinib along with standard topical triamcinolone helps adults with moderate-to-severe oral lichen planus get better than steroid ointment alone.

  Recruiting Phase 4 All India Institute of Medical Sciences, Bhubaneswar · Bhubaneswar, Odisha · NCT07131813

• Mucoadhesive patch treatment for symptomatic oral lichen planus

  This trial will test whether a mucoadhesive patch with clobetasol, with or without resveratrol, reduces pain and improves symptoms in adults with oral lichen planus.

  Recruiting Phase 2 University of Palermo · Palermo, Italy · NCT07100613

• Topical bromelain versus topical corticosteroid for oral lichen planus

  This trial will test whether a pineapple-derived enzyme gel (bromelain), alone or combined with a topical steroid, helps people with symptomatic oral lichen planus heal and have less pain.

  Recruiting Phase 2 Cairo University · Cairo, Cairo Governorate · NCT06981767

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.